Findings on cancer medication reveal protein regulation mechanism: Medication-based starvation of cancer cells

Immunomodulatory drugs, including the Contergan derivatives lenalidomide and pomalidomide, have significantly improved the therapy of hematologic malignancies such as multiple myeloma. Researchers at the Technical University of Munich (TUM) have now further decoded the mode of action in this class of medications.

Image: J. Stroh / TUM

read more